Skip to main content
. 2025 Sep 1;21(17):e1015–e1027. doi: 10.4244/EIJ-D-24-00952

Table 3. Cox regression analysis of clinical events in the validation cohort.

Univariable Multivariable
HR (95% CI) p-value HR (95% CI) p-value
MACE 1.66 (1.37-2.02) <0.001 1.47 (1.20-1.80) <0.001
Cardiac death 2.63 (1.63-4.24) <0.001 2.31 (1.42-3.77) <0.001
Hospitalisation for heart failure 1.97 (1.51-2.57) <0.001 1.68 (1.28-2.20) <0.001
Target lesion revascularisation 1.07 (0.73-1.57) 0.739 0.89 (0.59-1.32) 0.553
Repeat myocardial infarction 1.15 (0.75-1.76) 0.514 0.98 (0.62-1.55) 0.926
All-cause death 2.10 (1.39-3.17) <0.001 1.82 (1.18-2.80) 0.007
CI: confidence interval; HR: hazard ratio; MACE: major adverse cardiovascular events